Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification

Abstract

Clinicopathological classification appeared to be the strongest criterion for distinguishing among homogeneous prognoses of AAV. Individualizing the anti-MPO GPA subgroup does not appear to bring additional value to clinical practice, but multicentre studies are required to confirm this trend.